摘要:
A process for industrially advantageously producing a 1,4-trans-cyclohexanecarboxylic acid derivative (1) which has excellent VLA-4 inhibitory activity and is safe; and an intermediate advantageous for the production process. The process comprises converting a compound represented by the formula (I) into a compound represented by the formula (VI) according to the following scheme.
摘要:
An industrially usable process for producing a 1,2-cis-2-fluorocyclopropane-1-carboxylic ester. The process, which is for producing a compound represented by the following general formula (3): [Chemical formula 2] (wherein R1 represents C1-8 alkyl, etc.), comprises reacting a compound represented by the following general formula (1): [Chemical formula 1] [wherein X1 represents hydrogen, chlorine, bromine, or iodine and X2 represents hydrogen, chlorine, bromine, or iodine, provided that not both of X1 and X2 are hydrogen; and R1 is the same as defined above] with a reducing agent represented by the formula (2): M1BHmR2n (2-1) or M2(BHmR2n)2 (2-2) (wherein M1 represents an alkali metal; M2 represents an alkaline earth metal or zinc; R2 represents hydrogen, etc.; and m is an integer of 1-4 and n is an integer of 0-3, provided that the sum of m and n is 4) in the presence of an aprotic polar solvent and a Lewis acid such as, e.g., a halide of an element selected among boron, magnesium, aluminum, etc.
摘要翻译:提供了用于生产1,2-顺式-2-氟环丙烷-1-羧酸酯的工业上适用的方法。 制备由式(3)表示的化合物的方法:[其中R 1表示例如C 1 -C 8烷基],该方法包括使式(1)表示的化合物:[其中X 1表示氢 原子,氯原子,溴原子或碘原子; X 2表示氢原子,氯原子,溴原子或碘原子; X 1和X 2不同时为氢原子; 和R 1具有与式(3)中所定义的含义相同的含义)与式(2)表示的还原剂:ƒ€ƒ€ƒ€ƒ€ƒ€ƒM1 BH m R 2 n -1)或M 2(BH m R 2 n)2€ƒ€ƒ€ƒ(2-2)[其中M 1表示碱金属原子; M 2表示碱土金属原子或锌原子; R 2表示例如氢原子; m表示1〜4的整数, n表示0〜3的整数, 并且在非质子极性溶剂的存在下,m和n的和为4],以及路易斯酸如选自例如硼,镁和铝的原子的卤化物。
摘要:
A method of screening a drug acting on cell wall which involves: (1) the step of incubating microorganisms, in which a reporter protein is fixed as GPI anchor protein respectively to the cell wall and the cell membrane, in the presence of a test substance; (2) the step of assaying the reporter protein released in the cultures of the above microorganisms; and (3) the step of judging the test substance as a drug having a selective inhibitory action on the cell wall, in case where the reporter protein is released into the culture of the microorganism having the reporter protein fixed to the cell wall but not substantially released into the culture of the other microorganism having the reporter protein fixed to the cell membrane.
摘要:
A liquid preparation of sitafloxacin excellent in light stability, consisting of an aqueous solution containing both sitafloxacin and sodium chloride.
摘要:
A phospholipid derivative, utilizable for modification of liposomes and the like, which is a copolymer containing, as essential component units, a component unit A represented by the formula (1), a component unit B represented by the formula (2A) and/or the formula (2B), and a component unit C represented by the formula (3) ÄR and R represent hydrogen atom or methyl group, provided that R and R do not simultaneously represent methyl group; R represents a divalent hydrocarbon group having 1 to 3 carbon atoms; AO represents an oxyalkylene group having 2 to 4 carbon atoms; m represents an average molar number of the added oxyalkylene groups and is a number in the range represented as 4 represents hydrogen atom, a hydrocarbon group or acyl group having 1 to 20 carbon atoms; R CO and R CO represent an acyl group having 8 to 24 carbon atoms; R represents a divalent hydrocarbon group having 2 to 4 carbon atoms; and X and Y represent hydrogen atom, an alkali metal atom, ammonium or an organic ammoniumÜ wherein a molar ratio of the component unit A relative to a total of the component unit B and the component unit C is from 7/3 to 3/7, and the component unit C is contained at a ratio of from 1 to 4 moles per 1 mole of the copolymer.
摘要:
A particulate product which contains pantethine, a light silicic anhydride and a crystalline cellulose, wherein it contains the light silicic anhydride and the crystalline cellulose in a total amount such that provides an adsorptive capability of 0.6 or more. The particulate product comprising pantethine is excellent in fluidity, is free from problems such as blocking or the like, has particle diameters suitable for handling and exhibits good storage stability.
摘要:
Crystals of (1S,2S,3R,4S,5R,8R,9S,10R,13S)-4-acetoxy-2 -benzoyloxy-9,10-[(1S)-2-(dimethylamino)ethylidenedioxy]-5,20-epoxy-1-hydroxytax-11-en-13-yl (2R,3S)-3-(tert-butoxy- carbonylamino)-3-(3-fluoro-2-pyridyl)-2-hydroxypropionate, which exhibit in the powder X-ray diffraction pattern characteristic peaks at diffraction angles (2θ) of 6.2°, 10.3°, 10.7°, 11.4°, and 12.0°; and a process for production of the crystals which comprises the step of conducting crystallization by the use of an organic solvent selected from among ketones, nitriles and mixtures of both or a mixture of the organic solvent with water.
摘要:
Remedies for diseases caused by insulin resistance which contain as the active ingredient a substance having an activity of inhibiting the binding of the whole insulin receptor substrate-1 (IRS) or insulin receptor substrate-2 (IRS-2) or a part of the same to the whole 14-3-3 protein or a part of the same; and a method of screening remedies for diseases caused by insulin resistance which comprises assaying the above-mentioned binding inhibitory activity. Use of this screening method makes it possible to obtain remedies for various diseases induced by insulin resistance, such as diabetes, diabetic microangiopathies (diabetic nephropathy, diabetic neuropathy and diabetic retinopathy), impaired glucose tolerance, hyperinsulinemia, hyperlipemia, arteriosclerosis, hypertension, obesity, ischemic heart diseases, ischemic brain disorders, peripheral embolism, etc.